NFKB1 and diabetic kidney disease: Other therapeutic approaches which have been proposed in the context of DKD include attenuation of NF-kB signaling (Lee J. et al., 2012), breakdown of AGEs (Rabbani and Thornalley, 2018) or RAGE antagonism (Bongarzone et al., 2017).